Methods for the treatment of intractable myasthenia gravis

摘要

The present invention provides a method for treating myasthenia gravis (MG) in an individual in need of treatment by administering to a subject a substance that specifically binds to complement component 5 (C5). In certain embodiments, the substance that specifically binds to C5 is a binding protein, e. G., A anti-C5 antibody.